Piper Jaffray

E.L.F. Beauty Inc (NYSE: ELF) reports earnings Wednesday after the bell and Piper Jaffray expects the company to reiterate its guidance.  The Analyst Piper Jaffray's Erinn Murphy. The Rating Murphy downgraded E.L.F. Beauty Inc from Overweight to Neutral and lowered Piper Jaffray's...

Tivity Health Inc (NASDAQ: TVTY) plunged more than 30 percent Monday after its largest customer, UnitedHealth Group Inc (NYSE: UNH), expanded its competing Optum fitness benefit program for seniors on the Medicare Advantage plan. The program is seen to rival Tivity’s SilverSneakers for...

Shares of IMPINJ Inc (NASDAQ: PI) plunged more than 30 percent Thursday and hit a new 52-week low of $21.09 after the RFID tag-maker's first ever earnings report as a public company disappointed investors. As a result, Piper Jaffray's Troy Jensen downgraded Impinj's stock from...

With Zimmer Biomet Holdings Inc (NYSE: ZBH) reporting a third-quarter miss and slashing its guidance, Piper Jaffray downgraded shares of the Zimmer Biomet Holdings Inc (NYSE: ZBH).  Analyst Matt O'Brien dowgraded Zimmer Biomet from Overweight to Neutral and lowered his price target from...

Apple Inc. (NASDAQ: AAPL) investors are in for a treat, given expectations concerning a strong September quarter and the momentum around its tenth anniversary iPhone. The company is scheduled to release its fiscal fourth-quarter earnings after Thursday's market close. Fiscal Q4 Expectations...

Heading into its Wednesday earnings report, Facebook Inc (NASDAQ: FB) is decidedly well liked. The firm’s 42 Buy ratings are tempered by just two Sells and one Hold, according to TipRanks, which records an average price target of $191.33 with a range of $98 to $235. Recent trends back the...

Apple Inc. (NASDAQ: AAPL) investors haven’t known quite what to make of reports that iPhone 8 demand has fallen short of expectations. Low demand would typically be bad news for Apple. But in this case, it could simply be a sign that Apple customers are holding out for the iPhone X. As a...

Piper Jaffray upgraded shares of ServiceNow Inc (NYSE: NOW), citing channel checks and industry conversations, suggesting that the company is executing in the near term, while also laying foundation for a multi-year growth story still in its early stages. As such, the firm upgraded ServiceNow...

Ever wonder what Gene Munster’s favorite AI play is? Or the coffee flavor that fueled his famous Apple Inc. (NASDAQ: AAPL) coverage? Or his choice sneaker brand? Now’s your chance to ask. The Wall Street celebrity known for forward-thinking tech insight will visit Benzinga’s...

Down nearly 30 percent over the past six months, Ulta Beauty Inc (NASDAQ: ULTA) continues to lose support among Wall Street analysts. The latest to part ways with a bullish stance is Piper Jaffray's Erinn Murphy, who downgraded Ulta's stock from Overweight to Neutral with a price target...

Pre-open movers U.S. stock futures traded higher in early pre-market trade. Data on housing starts for September will be released at 8:30 a.m. ET. New York Federal Reserve Bank President William Dudley and Dallas Federal Reserve Bank President Robert Kaplan will speak in New York at 8:00 a.m. ET....

Piper Jaffray recently completed its semi-annual “Taking Stock With Teens” survey, which indicated that while big brands still reign supreme, young consumers are starting to show a preference for smaller niche brands. Teen spending overall moved down 4.4 percent year over year, while...

Citing its reseller checks and management transition, Piper Jaffray downgraded shares of Imperva Inc (NASDAQ: IMPV). The downgrade was blamed on four tenets: A deterioration in demand trends. The resignation of the CEO and chief financial officer in the third quarter. Potential for downside to...

The bullish case for owning Kraft Heinz Co (NASDAQ: KHC) can be made through expectations of ongoing consolidation within the packaged food industry, according to analysts at Piper Jaffray. The firm's Michael Lavery upgraded Kraft Heinz's stock rating from Neutral to Overweight but with a price...

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock initially jumped above $41 per share on Thursday after the FDA granted Breakthrough Designation to the company’s dementia-related psychosis drug candidate Pimavanserin. However, the stock quickly reversed direction as the market digested the...